Clinical Trial Update: Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update reports that denufosol inhalation solution for mild cystic fibrosis lung disease has completed, sponsored by Merck Sharp & Do…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Denufosol inhalation solution (denufosol tetra-sodium)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED